Raising the revenue forecast above analyst expectations generally leads to positive investor sentiment and can drive the stock price up in the short term. Given that Veracyte has surpassed the estimated revenue figures, this indicates strong performance and potential growth, likely resulting in increased investor confidence and a positive impact on the stock price.